Prostate Cancer Screening Attitudes and Continuing Education Needs of Primary Care Physicians

Curran, Vernon; Solberg, Shirley; Mathews, Maria; Church, Jon G.; Buehler, Sharon; Wells, Julie; Lopez, Tanya

doi:10.1207/s15430154jce2003_10

Cited by 26 publications

(38 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Applying the inclusion and exclusion criteria, 929 were excluded on the basis of the title and abstract (Kappa: 0.90) and 160 on the basis of the full text (Kappa: 0.95). Twenty articles were retained: 14 studies analysing the PCP's point of view [24][25][26][27][28][29][30][31][32][33][34][35][36][37] , 5 studies analysing the patient's point of view [38][39][40][41][42] , one study analysing both. 43 3.1.…”

Section: Resultsmentioning

confidence: 99%

“…26,31,33,34,37 Physicians reported high and rising rates of PSA testing from 1993 to 1998. 34 The number of PCPs recommending PSA testing of healthy men is also high in Canada (87.5% 28 last year. 41 Reported PSA screening rates were lower (24%) in the Australian study among patients 40 years of age and older.…”

Section: Pcps' Self-reported Practicesmentioning

confidence: 99%

“…). Indeed, PCPs are more likely to order PSA tests for patients who have a higher risk of prostate cancer due to a family history of prostate cancer [24][25][26][27][28][29]32,34,37 or are African-American. 26,27 PCPs are more likely to order PSA tests for patients who have low urinary track symptoms (LUTS) [24][25][26]30,32,33,43 , or an abnormal result from a digital rectal examination.…”

Section: Factors Influencing Psa Screening For Prostate Cancermentioning

confidence: 99%

See 2 more Smart Citations

The decision-making process in prostate cancer screening in primary care with a prostate-specific antigen: A systematic review

Vedel

Puts

Monette

et al. 2011

Journal of Geriatric Oncology

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

Section: Pcps' Self-reported Practicesmentioning

confidence: 99%

Section: Factors Influencing Psa Screening For Prostate Cancermentioning

confidence: 99%

See 1 more Smart Citation

The decision-making process in prostate cancer screening in primary care with a prostate-specific antigen: A systematic review

Vedel

Puts

Monette

et al. 2011

Journal of Geriatric Oncology

View full text Add to dashboard Cite

“…24 In a survey of 485 family physicians in Newfoundland and Labrador, Curran and colleagues found that although most respondents screened men 50 and older, there were divergent beliefs about the benefits of prostate cancer screening. 25 This study has notable limitations. Selection bias is possible since physicians with strong opinions on the subject may have been more likely to participate.…”

Section: Prostate Cancer Screening In Ontariomentioning

confidence: 94%

1920 Prostate Cancer Screening Attitudes and Practices of Family Physicians in Ontario

Allard¹,

Dason²,

Kapoor³

2012

Journal of Urology

View full text Add to dashboard Cite

Introduction: The utility of prostate cancer screening is controversial. We sought to determine whether Ontario's family physicians believe it is beneficial and to characterize their screening protocols. Methods: A survey was developed with input from urologists, family physicians and the Ontario Medical Association's Section on General and Family Practice. Questions covered three domains: (1) demographics, (2) beliefs about screening utility and (3) screening practices. All 7302 family physicians in Ontario were invited by email to complete the online survey. Results: A total of 969 physicians completed the survey; 955 (52.0% male, 48.0% female) were included. Most (80.97%) use prostate-specific antigen (PSA) and digital rectal examination (DRE) for screening; 9.4% use DRE alone and 7.15% PSA. Of the respondents, 8.3% do not offer prostate cancer screening. Most physicians begin offering screening at age 50 (72.9%) and stop at ages 70 or 80 (68.4%); 17.9% offer lifelong screening. In response to the statement "screening with DRE provides a survival benefit," 37.6% and 32.6 agreed and disagreed, respectively. For "screening with PSA provides a survival benefit," 43.3% agreed and 31.0% disagreed. For the statement "the benefits of prostate cancer screening outweigh the risks," 51.4% agreed and 22.0% disagreed. Discussion: Although 91.7% of respondents offer prostate cancer screening, they are divided over its utility. Only 51.4% were convinced that the benefits outweighed the harms. There is significant variability between physicians' screening protocols. A limitation of this study is the possibility of selection bias. Nevertheless, this is the largest sample of Ontario family physicians ever surveyed about prostate cancer screening and highlights divergent physician practices and a need for more conclusive evidence on screening utility.

show abstract

“…It is likely that the results can be extrapolated to the rest of the country, as these findings have been corroborated by other papers addressing the same question in Newfoundland and British Columbia. 11,12 Most importantly, the survey shows the need not only to provide clear and evidence-based guidelines, but also for better education on prostate cancer screening for family physicians. A significant onus of responsibility for this lies with our own association and members.…”

mentioning

confidence: 99%

The confusion surrounding prostate cancer screening faced by family physicians

Hoag¹,

So²

2012

CUAJ

View full text Add to dashboard Cite

Prostate Cancer Screening Attitudes and Continuing Education Needs of Primary Care Physicians

Cited by 26 publications

References 7 publications

The decision-making process in prostate cancer screening in primary care with a prostate-specific antigen: A systematic review

The decision-making process in prostate cancer screening in primary care with a prostate-specific antigen: A systematic review

1920 Prostate Cancer Screening Attitudes and Practices of Family Physicians in Ontario

The confusion surrounding prostate cancer screening faced by family physicians

Contact Info

Product

Resources

About